J&J Says Oklahoma’s $17.5 Billion Demand Goes Way Beyond Opioids

Aug. 1, 2019, 9:00 PM

The state of Oklahoma is seeking $17.5 billion in abatement costs from Johnson & Johnson over the opioid crisis, but the company says much of that money would address abuse of many drugs unrelated to opioids far into the future.

The six-week, non-jury trial wrapped up July 15, with final briefs filed July 31, and now Judge Thad Balkman must decide whether J&J is indeed the kingpin in the state’s opioid epidemic and then weigh how much, if any, abatement is appropriate.

The state is requesting that Balkman approve payments of $233 million per year from the New Brunswick, N.J.-based...

To read the full article log in.

Learn more about a Bloomberg Law subscription.